Search - tctmd.com

Displaying 241 - 260 of 411

Sort: Relevancy | Date

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Debate: LAA Closure Should Be Considered in Most Patients With Nonvalvular Atrial Fibrillation!

Presenter: Christopher B. Granger, Horst Sievert, Maurice Buchbinder

October 30, 2017

Presentation TCT 2017

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Presenter: Thomas H. Maloney, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Presenter: Christopher B. Granger, Horst Sievert, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Presenter: Christopher B. Granger, Horst Sievert, Pascal Vranckx

October 30, 2017

Presentation TCT 2017

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Presenter: Christopher B. Granger, Horst Sievert, Renu Virmani

October 30, 2017

Presentation CDM 2017

Current Approach of Atrial Fibrillation Management

Presenter: Wilber W. Su

October 06, 2017

Presentation LAA 2017

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

Presenter: Zahid Amin

July 22, 2017

Presentation LAA 2017

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Presenter: Brian Whisenant

July 22, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

Presentation EuroPCR 2017

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

Presentation SCAI 2017

Results From The BRAVO 3 Randomized Trial

Presenter: Usman Baber

May 15, 2017

Presentation SWVS 2017

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Presenter: Ankur Kalra

May 06, 2017

Presentation SIF 2017

Thromboembolic Prophylaxis in Atrial Fibrillation

Presenter: Samir Kapadia

March 09, 2017

Presentation CRT 2017

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Presenter: Chadi Alraies

February 22, 2017

Presentation JIM 2017

Appendix Closure is the Solution

Presenter: Horst Sievert

February 10, 2017

Advertisement

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Debate: LAA Closure Should Be Considered in Most Patients With Nonvalvular Atrial Fibrillation!

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Current Approach of Atrial Fibrillation Management

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Results From The BRAVO 3 Randomized Trial

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Thromboembolic Prophylaxis in Atrial Fibrillation

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Appendix Closure is the Solution

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content